- Source : Press Release
- Date : 2020-10-06
- Companies : Roche
Roche Diagnostics Reaffirms Corporate Missions on 30th Anniversary
For the past 30 years, Roche Diagnostics Korea has been contributing to improving people's health through the supply of innovative products and services, the company's top manager said Tuesday.
In the process, the company has established itself as a reliable partner for healthcare workers and patients in Korea, he added.
"We will continue to pursue innovation under the Roche Group's mission of 'doing now what patients need next' and open a new future of healthcare together," Roche Diagnostics Korea General Manager Johnny Tse said at a news conference to celebrate the company's 30th anniversary.
Kim Hyung-ju, head of the marketing division, stressed that Roche Diagnostic Korea has been quickly providing various test solutions to diagnose Covid-19 in Korea. "The company started by providing a nucleic acid extraction reagent, a key step in the Covid-19 diagnostic test, for Korean healthcare workers through the support from the Swiss headquarters in February," Kim said, adding that the company has supplied more than 1.3 million tests as of Sept. 18.
The company also launched cobas6800, a polymerase chain reaction (PCR) test, in March.
"The test kit was the first of its kind to obtain an emergency use approval (EUA) from the U.S. Food and Drug Administration," she said. "The company received EUA approval for Elecsys Anti-SARS-CoV-2, which measures antibodies against Covid-19 in the blood to help identify immune responses, and an emergency test system that simultaneously tests Covid-10 and influenza."
These are antibody testing systems that help establish quarantine policies by investigating serological prevalence within the group, analyzing clinical, epidemiological characteristics of infected individuals, verifying immunity and follow-up management, and infectivity by medical staff, Kim added.
The EUA-approved test kits that can simultaneously detect Covid-19 and influenza are undergoing review in Korea.
Kim also stressed the company not only supplies innovative products and services but also works to carry out various social contribution activities, such as charity walks to help African children, support low-income children in Korea, provide aids for abused children, and help cure young people with diabetes.
"Roche Diagnostics has donated 100 million won ($86,000) jointly with Roche Korea to overcome the damage of Covid-19 in March," Kim said. "We will actively contribute to society by providing tests suitable for various medical environments and raising funds to support the vulnerable."